Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL488646

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC

Basic Information

ChEMBL ID CHEMBL488646
Phase Preclinical
Structure Type MOL
InChI Key ZFKGDYZACMFEDS-UHFFFAOYSA-N
20
Targets
20
Activities
1
Assay Types
0
PK Parameters
20
Publications
0
Known Names

Molecular Properties

450.5
MW (Da)
4.48
ALogP
6
HBA
1
HBD
71.0
PSA (Ų)
0.57
QED
0
Ro5 Violations
7
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C26H30N2O5
MW 450.54
Aromatic Rings 3
Heavy Atoms 33
NP-Likeness -0.05

Activity Summary

IC50 20 meas. best 5.36

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Proto-oncogene tyrosine-protein kinase Src
CHEMBL267
IC50 5.36 5.36 4400.0 1
Vascular endothelial growth factor receptor 2
CHEMBL279
IC50 5.36 5.36 4400.0 1
Vascular endothelial growth factor receptor 3
CHEMBL1955
IC50 5.32 5.32 4800.0 1
Insulin-like growth factor 1 receptor
CHEMBL1957
IC50 5.11 5.11 7700.0 1
Epidermal growth factor receptor
CHEMBL203
IC50 5.05 5.05 9000.0 1
Mitogen-activated protein kinase kinase kinase 8
CHEMBL4899
IC50 5.02 5.02 9600.0 1
Angiopoietin-1 receptor
CHEMBL4128
IC50 4.96 4.96 11000.0 1
Ephrin type-B receptor 4
CHEMBL5147
IC50 4.7 4.7 20000.0 1
Receptor-type tyrosine-protein kinase FLT3
CHEMBL1974
IC50 4.7 4.7 20000.0 1
Cyclin-dependent kinase 2
CHEMBL301
IC50 4.64 4.64 23000.0 1
Receptor tyrosine-protein kinase erbB-2
CHEMBL1824
IC50 4.6 4.6 25000.0 1
Cyclin-dependent kinase 4/cyclin D1
CHEMBL1907601
IC50 4.57 4.57 27000.0 1
Insulin receptor
CHEMBL1981
IC50 4.57 4.57 27000.0 1
Focal adhesion kinase 1
CHEMBL2695
IC50 4.55 4.55 28000.0 1
Serine/threonine-protein kinase PLK4
CHEMBL3788
IC50 4.55 4.55 28000.0 1
Hepatocyte growth factor receptor
CHEMBL3717
IC50 4.54 4.54 29000.0 1
Aurora kinase A
CHEMBL4722
IC50 4.52 4.52 30000.0 1
Serine/threonine-protein kinase B-raf
CHEMBL5145
IC50 4.42 4.42 38000.0 1
Platelet-derived growth factor receptor beta
CHEMBL1913
IC50 4.42 4.42 38000.0 1
Aurora kinase B
CHEMBL2185
IC50 4.37 4.37 43000.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Vascular endothelial growth factor receptor 2 IC50 = 4400.0 nM 5.36 Inhibition of human recombinant VEGFR2 18529047
Proto-oncogene tyrosine-protein kinase Src IC50 = 4400.0 nM 5.36 Inhibition of human recombinant SRC 18529047
Vascular endothelial growth factor receptor 3 IC50 = 4800.0 nM 5.32 Inhibition of human recombinant VEGFR3 18529047
Insulin-like growth factor 1 receptor IC50 = 7700.0 nM 5.11 Inhibition of human recombinant IGF1R 18529047
Epidermal growth factor receptor IC50 = 9000.0 nM 5.05 Inhibition of human recombinant EGFR 18529047
Mitogen-activated protein kinase kinase kinase 8 IC50 = 9600.0 nM 5.02 Inhibition of human recombinant COT 18529047
Angiopoietin-1 receptor IC50 = 11000.0 nM 4.96 Inhibition of human recombinant TIE2 18529047
Ephrin type-B receptor 4 IC50 = 20000.0 nM 4.7 Inhibition of human recombinant EPHB4 18529047
Receptor-type tyrosine-protein kinase FLT3 IC50 = 20000.0 nM 4.7 Inhibition of human recombinant FLT3 18529047
Cyclin-dependent kinase 2 IC50 = 23000.0 nM 4.64 Inhibition of human recombinant CDK2/cyclin A 18529047
Receptor tyrosine-protein kinase erbB-2 IC50 = 25000.0 nM 4.6 Inhibition of human recombinant ERBB2 18529047
Cyclin-dependent kinase 4/cyclin D1 IC50 = 27000.0 nM 4.57 Inhibition of human recombinant CDK4/cyclin D1 18529047
Insulin receptor IC50 = 27000.0 nM 4.57 Inhibition of human recombinant INS-R 18529047
Focal adhesion kinase 1 IC50 = 28000.0 nM 4.55 Inhibition of human recombinant FAK 18529047
Serine/threonine-protein kinase PLK4 IC50 = 28000.0 nM 4.55 Inhibition of human recombinant SAK 18529047
Hepatocyte growth factor receptor IC50 = 29000.0 nM 4.54 Inhibition of human recombinant MET 18529047
Aurora kinase A IC50 = 30000.0 nM 4.52 Inhibition of human recombinant Aurora A 18529047
Serine/threonine-protein kinase B-raf IC50 = 38000.0 nM 4.42 Inhibition of human recombinant B-Raf-V600E mutant 18529047
Platelet-derived growth factor receptor beta IC50 = 38000.0 nM 4.42 Inhibition of human recombinant PDGFRbeta 18529047
Aurora kinase B IC50 = 43000.0 nM 4.37 Inhibition of human recombinant Aurora B 18529047

Literature References

PubMed DOI Target Context # Activities
18529047 10.1021/jm8001185 Proto-oncogene tyrosine-protein kinase Src 1
18529047 10.1021/jm8001185 Mitogen-activated protein kinase kinase kinase 8 1
18529047 10.1021/jm8001185 Angiopoietin-1 receptor 1
18529047 10.1021/jm8001185 Serine/threonine-protein kinase PLK4 1
18529047 10.1021/jm8001185 Platelet-derived growth factor receptor beta 1
18529047 10.1021/jm8001185 Hepatocyte growth factor receptor 1
18529047 10.1021/jm8001185 Insulin receptor 1
18529047 10.1021/jm8001185 Receptor-type tyrosine-protein kinase FLT3 1
18529047 10.1021/jm8001185 Vascular endothelial growth factor receptor 3 1
18529047 10.1021/jm8001185 Vascular endothelial growth factor receptor 2 1
18529047 10.1021/jm8001185 Aurora kinase A 1
18529047 10.1021/jm8001185 Insulin-like growth factor 1 receptor 1
18529047 10.1021/jm8001185 Focal adhesion kinase 1 1
18529047 10.1021/jm8001185 Receptor tyrosine-protein kinase erbB-2 1
18529047 10.1021/jm8001185 Ephrin type-B receptor 4 1
18529047 10.1021/jm8001185 Epidermal growth factor receptor 1
18529047 10.1021/jm8001185 Cyclin-dependent kinase 4/cyclin D1 1
18529047 10.1021/jm8001185 Cyclin-dependent kinase 2 1
18529047 10.1021/jm8001185 Serine/threonine-protein kinase B-raf 1
18529047 10.1021/jm8001185 Aurora kinase B 1

Data from ChEMBL 36 via Core Engine